United States · Series A startup

Who invested in Neuraptive Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $12MDec 2018
Investors
1
See who backed them

The rounds

  1. Dec 2018
    Series A$12M

    Reported by FinSMEsSEC filing: $10M sold, first sale Dec 2018

Everyone who backed them

New RheinPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neuraptive Therapeutics

Who invested in Neuraptive Therapeutics?

Neuraptive Therapeutics's investors include New Rhein.

How much has Neuraptive Therapeutics raised?

Neuraptive Therapeutics has raised $12M across 1 round since 2018.

When did Neuraptive Therapeutics last raise?

Neuraptive Therapeutics's most recent round was a Series A of $12M in Dec 2018.

What was Neuraptive Therapeutics's biggest round?

Its most recent round, $12M in Dec 2018, is also its largest on record.

Who backed Neuraptive Therapeutics first?

Neuraptive Therapeutics's first round on record, in Dec 2018, was backed by New Rhein.

What stage is Neuraptive Therapeutics at?

Neuraptive Therapeutics's latest named round is a Series A, in Dec 2018.

Where is Neuraptive Therapeutics based?

Neuraptive Therapeutics is based in the United States.

Companies like Neuraptive Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.